Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laux

Showing results (221-230 of 1,558) with videos related to

Pageof 156
Sort By:
Journal of Neural Transmission. Supplementum|November 7, 2007
Therapeutic drug monitoring of antidepressants--clinical aspectsG Laux, P Baumann, C Hiemke, et al.
Journal of Orthopaedic Surgery and Research|July 3, 2007
Osteoarthritis: quality of life, comorbidities, medication and health service utilization assessed in a large sample of primary care patientsThomas Rosemann, Gunter Laux, Joachim Szecsenyi
Regulation & Governance|March 4, 2024
Trustworthy artificial intelligence and the European Union AI act: On the conflation of trustworthiness and acceptability of riskJohann Laux, Sandra Wachter, Brent Mittelstadt
Toxics|October 21, 2017
Time-of-Flight Secondary Ion Mass Spectrometry (ToF-SIMS): A New Tool for the Analysis of Toxicological Effects on Single Cell LevelHarald Jungnickel, Peter Laux, Andreas Luch
Der Nervenarzt|June 29, 2014
[Dementia and driving]A Brunnauer, V Buschert, G Laux
Computer Law & Security Review : the International Journal of Technology Law and Practice|December 1, 2025
Three Pathways for Standardisation and Ethical Disclosure by Default under the European Union Artificial Intelligence ActJohann Laux, Sandra Wachter, Brent Mittelstadt
Psychiatrische Praxis|August 1, 1989
[Treatment of depression using MAO-A inhibitors: an open study of a direct switch from moclobemide to tri-/tetracyclic antidepressants]T Becker, M Struck, G Laux
Cannabis and Cannabinoid Research|November 3, 2025
Effects of Voluntary Ingestion of Synthetic Delta-9-Tetrahydrocannabinol on the Hedonic Value of Rewarding and Aversive Substances and CB1 Receptor ExpressionDylan A Laux, Mary E Cain
Development (Cambridge, England)|June 19, 2002
The WUSCHEL and SHOOTMERISTEMLESS genes fulfil complementary roles in Arabidopsis shoot meristem regulationMichael Lenhard, Gerd Jürgens, Thomas Laux
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 25, 2018
Synthesis and structure‑activity‑relationship of 3,4‑Diaryl‑1H‑pyrrolo[2,3‑b]pyridines as irreversible Inhibitors of mutant EGFR‑L858R/T790MMarcel Günther, Julian Laux, Stefan Laufer
Pageof 156

Showing results (221-230 of 1,558) with videos related to

Sort By:
Pageof 156
Journal of Neural Transmission. Supplementum|November 7, 2007
Therapeutic drug monitoring of antidepressants--clinical aspectsG Laux, P Baumann, C Hiemke, et al.
Journal of Orthopaedic Surgery and Research|July 3, 2007
Osteoarthritis: quality of life, comorbidities, medication and health service utilization assessed in a large sample of primary care patientsThomas Rosemann, Gunter Laux, Joachim Szecsenyi
Regulation & Governance|March 4, 2024
Trustworthy artificial intelligence and the European Union AI act: On the conflation of trustworthiness and acceptability of riskJohann Laux, Sandra Wachter, Brent Mittelstadt
Toxics|October 21, 2017
Time-of-Flight Secondary Ion Mass Spectrometry (ToF-SIMS): A New Tool for the Analysis of Toxicological Effects on Single Cell LevelHarald Jungnickel, Peter Laux, Andreas Luch
Der Nervenarzt|June 29, 2014
[Dementia and driving]A Brunnauer, V Buschert, G Laux
Computer Law & Security Review : the International Journal of Technology Law and Practice|December 1, 2025
Three Pathways for Standardisation and Ethical Disclosure by Default under the European Union Artificial Intelligence ActJohann Laux, Sandra Wachter, Brent Mittelstadt
Psychiatrische Praxis|August 1, 1989
[Treatment of depression using MAO-A inhibitors: an open study of a direct switch from moclobemide to tri-/tetracyclic antidepressants]T Becker, M Struck, G Laux
Cannabis and Cannabinoid Research|November 3, 2025
Effects of Voluntary Ingestion of Synthetic Delta-9-Tetrahydrocannabinol on the Hedonic Value of Rewarding and Aversive Substances and CB1 Receptor ExpressionDylan A Laux, Mary E Cain
Development (Cambridge, England)|June 19, 2002
The WUSCHEL and SHOOTMERISTEMLESS genes fulfil complementary roles in Arabidopsis shoot meristem regulationMichael Lenhard, Gerd Jürgens, Thomas Laux
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 25, 2018
Synthesis and structure‑activity‑relationship of 3,4‑Diaryl‑1H‑pyrrolo[2,3‑b]pyridines as irreversible Inhibitors of mutant EGFR‑L858R/T790MMarcel Günther, Julian Laux, Stefan Laufer
Pageof 156